Logo CICANCER
Intranet Colaborate

Old CIC Events

Functional analysis of the role of rap1gds1 and RHOA in KRAS-driven lung adenocarcinoma 30/05/2022

Functional analysis of the role of rap1gds1 and RHOA in KRAS-driven lung adenocarcinoma

Marta Román Moreno — School of Medicine; University of California, San Francisco

TESIS DOCTORAL: Leucemia infantil de células B: preleucemia, estrés inmunológico y prevención. 27/05/2022

TESIS DOCTORAL: Leucemia infantil de células B: preleucemia, estrés inmunológico y prevención.

Ana Casado García — Centro de Investigación del Cáncer

Functional correlations between genotype and phenotype in non-muscle myosin 2A mutations 26/05/2022

Functional correlations between genotype and phenotype in non-muscle myosin 2A mutations

Clara Llorente-González — Centro de Investigación del Cáncer (CIC-IBMCC), Salamanca

Role of C3G in platelet spreading and vesicle trafficking 19/05/2022

Role of C3G in platelet spreading and vesicle trafficking

Cristina Fernández Infante — Centro de Investigación del Cáncer (CIC-IBMCC)

Regulation of tumor immune microenvironment using advanced nano-immunotherapy 12/05/2022

Regulation of tumor immune microenvironment using advanced nano-immunotherapy

Helena Florindo — Instituto de Investigação do Medicamento (iMed.ULisboa), Faculdade de Farmácia da Universidade de Lisboa, Lisbon, Portugal

Stem cells, therapy resistance and metastasis in colorectal cancer 05/05/2022

Stem cells, therapy resistance and metastasis in colorectal cancer

Eduard Batlle — Institute for Research in Biomedicine (IRB Barcelona)

Activation-induced expression of non-muscle myosin IIB shapes lymphocyte polarity and the immune synapse and T cell activation 28/04/2022

Activation-induced expression of non-muscle myosin IIB shapes lymphocyte polarity and the immune synapse and T cell activation

María Millán — Centro de Investigación del Cáncer (CIC-IBMCC)

Collective downregulation of a group of tumor suppressors in response to EGF: The role of TSHZ2 in cancer progression 21/04/2022

Collective downregulation of a group of tumor suppressors in response to EGF: The role of TSHZ2 in cancer progression

Mary Luz Uribe Ríos — Centro de Investigación del Cáncer (CIC-IBMCC)

exhibición de los posters de los estudiantes de Máster 20/04/2022

exhibición de los posters de los estudiantes de Máster

Estudiantes máster de biología y clínica del cáncer — CIC

The amoeboid state as part of the epithelial-to-mesenchymal transition programme 07/04/2022

The amoeboid state as part of the epithelial-to-mesenchymal transition programme

Prof. Victoria Sanz-Moreno — Barts Cancer Institute Queen Mary University of London [London, UK]

Characterization of NOMO1 loss in early-onset colorectal cancer 24/03/2022

Characterization of NOMO1 loss in early-onset colorectal cancer

Abel J. Martel Martel — Centro de Investigación del Cáncer-Hospital Universitario de Salamanca

Stromal cytokine signalling promotes breast cancer progression by reprograming the tumor microenvironment 17/03/2022

Stromal cytokine signalling promotes breast cancer progression by reprograming the tumor microenvironment

María Muñoz Caffarel — del Instituto de Investigación Sanitaria Biodonostia/ Hospital Donostia de San Sebastián